Literature DB >> 6297713

A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma.

H Nielsen, J Bennedsen, S O Larsen, P Dombernowsky, K Viskum.   

Abstract

Absolute circulating number and functions of blood monocytes (i.e., pinocytosis, phagocytosis, and chemotaxis) were studied in 25 patients with untreated bronchogenic carcinoma and in 28 control subjects. The absolute circulating monocyte count was increased in 20 (80%) of the patients. There was no difference in the pinocytic and phagocytic activity of patient and control monocytes. In contrast, patient monocytes showed depressed chemotactic responsiveness. This defect was more severe in small cell anaplastic carcinoma than in the other histologic types of bronchogenic carcinoma (P = 0.0001), and may explain the difference in macrophage infiltration seen in solid tumours of the lung. There was no correlation between chemotaxis and clinical stage. Depressed chemotaxis may be related to a plasma factor, since patient plasma inhibited the chemotaxis of control monocytes as well as the activity of chemotactic agents. The defective chemotaxis and the presence of plasma inhibitory activity may interfere with the ability of blood monocytes to accumulate as macrophages in tumour sites.

Entities:  

Mesh:

Year:  1982        PMID: 6297713     DOI: 10.1007/bf00205307

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  35 in total

1.  Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination.

Authors:  H H Hansen; P Dombernowsky; M Hansen; F Hirsch
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

2.  Altered expression of human monocyte Fc receptors in malignant disease.

Authors:  J Rhodes
Journal:  Nature       Date:  1977-01-20       Impact factor: 49.962

3.  Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma.

Authors:  R H Rubin; A B Cosimi; E J Goetzl
Journal:  Clin Immunol Immunopathol       Date:  1976-11

4.  Defective leukotaxis in monocytes from patients with pulmonary tuberculosis.

Authors:  P B Campbell
Journal:  J Infect Dis       Date:  1979-04       Impact factor: 5.226

5.  Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages.

Authors:  J B Hibbs
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

6.  Abnormal monocyte chemotactic response in cancer patients.

Authors:  D A Boetcher; E J Leonard
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

7.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

8.  Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal.

Authors:  R Snyderman; H F Seigler; L Meadows
Journal:  J Natl Cancer Inst       Date:  1977-01       Impact factor: 13.506

9.  Effect of autologous and homologous serum and circulating immune complexes on monocyte functions of patients with solid tumours.

Authors:  A Celada; T Aguado; P H Lambert; A Cruchaud
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

10.  Phagocytosis of monocytes in cancer patients.

Authors:  B M Kuntz; R M Kuntz; E D Albert
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26
View more
  7 in total

1.  Enhancement of defective monocyte function during immunotherapy with recombinant interferon.

Authors:  H Nielsen; P Ernst
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Normalization of defective monocyte chemotaxis during chemotherapy in patients with small cell anaplastic carcinoma of the lung.

Authors:  H Nielsen; J Bennedsen; P Dombernowsky
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

3.  Monocyte antibody-dependent cellular cytotoxicity in cancer patients.

Authors:  N J De Young; P G Gill
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 4.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

5.  Monocyte chemotaxis in patients with nonseminomatous testicular carcinoma. Effect of chemotherapy.

Authors:  H Nielsen; M Rørth; J Bennedsen
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients.

Authors:  S Sone; T Utsugi; P Tandon; H Yanagawa; A Okubo; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients.

Authors:  S Sone; E Kunishige; F Fawzy; H Yanagawa; A Nii; K Maeda; S Atagi; Y Heike; Y Nishioka; K Mizuno
Journal:  Jpn J Cancer Res       Date:  1991-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.